BRNS
Price
$0.92
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
36.95M
39 days until earnings call
SLN
Price
$5.79
Change
+$0.25 (+4.51%)
Updated
Jun 27 closing price
Capitalization
226.71M
46 days until earnings call
Interact to see
Advertisement

BRNS vs SLN

Header iconBRNS vs SLN Comparison
Open Charts BRNS vs SLNBanner chart's image
Barinthus Biotherapeutics
Price$0.92
Change-$0.00 (-0.00%)
Volume$2.91K
Capitalization36.95M
Silence Therapeutics
Price$5.79
Change+$0.25 (+4.51%)
Volume$141.07K
Capitalization226.71M
BRNS vs SLN Comparison Chart in %
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. SLN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Buy and SLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BRNS: $0.92 vs. SLN: $5.79)
Brand notoriety: BRNS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 8% vs. SLN: 88%
Market capitalization -- BRNS: $36.95M vs. SLN: $226.71M
BRNS [@Biotechnology] is valued at $36.95M. SLN’s [@Biotechnology] market capitalization is $226.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 3 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • BRNS’s TA Score: 3 bullish, 5 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BRNS and SLN are a bad buy in the short-term.

Price Growth

BRNS (@Biotechnology) experienced а +9.68% price change this week, while SLN (@Biotechnology) price change was +2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

SLN is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($227M) has a higher market cap than BRNS($37M). SLN YTD gains are higher at: -15.843 vs. BRNS (-23.634). BRNS has higher annual earnings (EBITDA): -58.89M vs. SLN (-71.65M). SLN has more cash in the bank: 137M vs. BRNS (99.1M). SLN has less debt than BRNS: SLN (60K) vs BRNS (11.9M). SLN has higher revenues than BRNS: SLN (27.7M) vs BRNS (15M).
BRNSSLNBRNS / SLN
Capitalization37M227M16%
EBITDA-58.89M-71.65M82%
Gain YTD-23.634-15.843149%
P/E RatioN/AN/A-
Revenue15M27.7M54%
Total Cash99.1M137M72%
Total Debt11.9M60K19,833%
TECHNICAL ANALYSIS
Technical Analysis
BRNSSLN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
89%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTQQF5.621.38
+32.55%
BTQ Technologies Corp.
FINGF41.660.02
+0.05%
Finning International Inc.
AGPYF0.16N/A
N/A
Agile Group Holdings Limited
LDSVF15947.54N/A
N/A
Lindt & Sprungli AG
TAJIF0.04N/A
N/A
Tajiri Resources Corp

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
N/A
NGNE - BRNS
51%
Loosely correlated
-2.47%
NRIX - BRNS
32%
Poorly correlated
+0.17%
ASBP - BRNS
26%
Poorly correlated
-7.03%
CRNX - BRNS
25%
Poorly correlated
-0.10%
SLN - BRNS
25%
Poorly correlated
+4.51%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+4.51%
CLLS - SLN
43%
Loosely correlated
-2.54%
NGNE - SLN
36%
Loosely correlated
-2.47%
ANNX - SLN
35%
Loosely correlated
-1.63%
IDYA - SLN
34%
Loosely correlated
-4.13%
STOK - SLN
33%
Loosely correlated
-1.77%
More